Abstract
RNA interference (RNAi) is a posttranscriptional regulatory mechanism that employs siRNA. It typically results in the degradation of a target mRNA that encodes a particular protein. Treatment with siRNA therapeutics requires the use of an effective drug delivery system to assist in delivering these therapeutics into the cytoplasm of the transfected cells. Here we describe the transfection of melanoma cancer cells with siRNA using cationic niosome nanoparticles as a delivery system. The method of niosome preparation is first introduced and is followed by complex formation with siRNA and the transfection method.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Obeid MA, Tate RJ, Mullen AB, Ferro VA (2018) Lipid-based nanoparticles for cancer treatment. In: Grumezescu AM (ed) Lipid nanocarriers for drug targeting. Elsevier, New York
Higuchi Y, Kawakami S, Hashida M (2010) Strategies for in vivo delivery of siRNAs. BioDrugs 24(3):195–205
Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA (2017) Formulation of nonionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells. Mol Pharm 14(7):2450–2458
Alyamani H, Obeid MA, Tate RJ, Ferro VA (2019) Exosomes: fighting cancer with cancer. Ther Deliv 10(1):37–61
Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA (2019) Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown. J Liposome Res 29(3):229–238
Uchegbu IF, Florence AT (1995) Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 58(1):1–55
Obeid MA, Khadra I, Mullen AB, Tate RJ, Ferro VA (2017) The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics. Int J Pharm 516(1–2):52–60
Obeid MA, Gebril AM, Tate RJ, Mullen AB, Ferro VA (2017) Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods. Int J Pharm 521(1–2):54–60
Obeid MA, Teeravatcharoenchai T, Connell D, Niwasabutra K, Hussain M, Carter K, Ferro VA (2020) Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. J Liposome Res. https://doi.org/10.1080/08982104.2020.1768110
Zhou C, Mao Y, Sugimoto Y, Zhang Y, Kanthamneni N, Yu B, Brueggemeier RW, Lee LJ, Lee RJ (2011) SPANosomes as delivery vehicles for small interfering RNA (siRNA). Mol Pharm 9(2):201–210
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Obeid, M.A. et al. (2021). siRNA Delivery to Melanoma Cells with Cationic Niosomes. In: Hargadon, K.M. (eds) Melanoma. Methods in Molecular Biology, vol 2265. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1205-7_42
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1205-7_42
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1204-0
Online ISBN: 978-1-0716-1205-7
eBook Packages: Springer Protocols